Cardiac resynchronization therapy: a novel adjunct to the treatment and prevention of systemic right ventricular failure
Language English Country United States Media print
Document type Evaluation Study, Journal Article, Research Support, Non-U.S. Gov't
PubMed
15519030
DOI
10.1016/j.jacc.2004.08.044
PII: S0735-1097(04)01719-X
Knihovny.cz E-resources
- MeSH
- Bundle-Branch Block physiopathology therapy MeSH
- Child MeSH
- Echocardiography, Doppler MeSH
- Adult MeSH
- Ventricular Dysfunction, Right physiopathology prevention & control MeSH
- Electrocardiography MeSH
- Cardiac Pacing, Artificial * MeSH
- Pacemaker, Artificial MeSH
- Humans MeSH
- Adolescent MeSH
- Follow-Up Studies MeSH
- Postoperative Complications etiology physiopathology MeSH
- Heart Ventricles diagnostic imaging physiopathology MeSH
- Stroke Volume physiology MeSH
- Treatment Outcome MeSH
- Check Tag
- Child MeSH
- Adult MeSH
- Humans MeSH
- Adolescent MeSH
- Publication type
- Journal Article MeSH
- Evaluation Study MeSH
- Research Support, Non-U.S. Gov't MeSH
OBJECTIVES: This study aimed to evaluate the technical feasibility and hemodynamic benefit of cardiac resynchronization therapy (CRT) in patients with systemic right ventricle (RV). BACKGROUND: Patients with a systemic RV are at high risk of developing heart failure. Cardiac resynchronization therapy may improve RV function in those with electromechanical dyssynchrony. METHODS: Eight patients (age 6.9 to 29.2 years) with a systemic RV and right bundle-branch block (n = 2) or pacing from the left ventricle (LV) (n = 6) with a QRS interval of 161 +/- 21 ms underwent CRT (associated with cardiac surgery aimed at decrease in tricuspid regurgitation in 3 of 8 patients) and were followed-up for a median of 17.4 months. RESULTS: Change from baseline rhythm to CRT was accompanied by a decrease in QRS interval (-28.0%, p = 0.002) and interventricular mechanical delay (-16.7%, p = 0.047) and immediate improvement in the RV filling time (+10.9%, p = 0.002), Tei index (-7.7%, p = 0.008), estimated RV maximum +dP/dt(+45.9%, p = 0.007), aortic velocity-time integral (+7.0%, p = 0.028), and RV ejection fraction by radionuclide ventriculography (+9.6%, p = 0.04). The RV fractional area of change increased from a median of 18.1% before resynchronization to 29.5% at last follow-up (p = 0.008) without a significant change in the end-diastolic area (+4.0%, p = NS). CONCLUSIONS: The CRT yielded improvement in systemic RV function in patients with spontaneous or LV pacing-induced electromechanical dyssynchrony and seems to be a promising adjunct to the treatment and prevention of systemic RV failure.
References provided by Crossref.org
Cardiac resynchronization therapy in congenital heart disease